Friday 6 November 2026 Export LH’s income statement to Excel — free account

Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.

Revenue: +6.92%
EPS: +3.18%
Free cash flow: +44.7%
Total debt: +3.21%

Quarter to September 2026, against a year earlier

364.47 1.17 +0.32%

Follow LH

Alert me

Market cap: $29.5B
P/E: 29.5×
Fwd P/E: 26.7×
Dividend yield: 0.79%
F-score: 8/9
Altman Z: 3.02
Beneish M: −2.55
Dividend safety: 74/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Labcorp Holdings Inc. 8-K filed Aug 14, 2026

Period ended Aug 11, 2026 · Filed Aug 14, 2026 · accepted 8:55 AM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers

Red flags

Officer departure Aug 14, 2026
Labcorp Holdings Inc. reported the departure of an officer or director

8-K filed Aug 14, 2026 · The filing · sec.gov